{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:24:19Z","timestamp":1790414659314,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009109","name":"Bayer Pharma AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jvs.2022.11.062","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T12:13:08Z","timestamp":1670242388000},"page":"1107-1118.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits"],"prefix":"10.1016","volume":"77","author":[{"given":"Nicholas","family":"Govsyeyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1012-7307","authenticated-orcid":false,"given":"Mark","family":"Nehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayer","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Dorigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Gudz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dainis","family":"Krievins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Norgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Piffaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Szalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Sillesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Wohlauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Szarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert M.","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren H.","family":"Capell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie N.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Muehlhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd P.","family":"Haskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2022.11.062_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2022.11.062_bib2","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2022.11.062_bib3","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/CIRCULATIONAHA.114.013440","article-title":"The contemporary safety and effectiveness of lower extremity bypass surgery and peripheral endovascular interventions in the treatment of symptomatic peripheral arterial disease","volume":"132","author":"Tsai","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.11.062_bib4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jvs.2007.08.033","article-title":"Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial","volume":"46","author":"Schanzer","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1067\/mva.2002.124628","article-title":"Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein","volume":"35","author":"Chew","year":"2002","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jvs.2016.01.042","article-title":"Alternative conduit for infrageniculate bypass in patients with critical limb ischemia","volume":"64","author":"Moreira","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0002-9610(87)90803-8","article-title":"Autogenous reversed vein bypass for lower extremity ischemia in patients with absent or inadequate greater saphenous vein","volume":"153","author":"Taylor","year":"1987","journal-title":"Am J Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jvs.2010.04.013","article-title":"Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia","volume":"52","author":"Arvela","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejvs.2020.06.016","article-title":"Alternative venous conduits for below knee bypass in the absence of ipsilateral great saphenous vein","volume":"60","author":"Nierlich","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejvs.2003.12.027","article-title":"Saphenous vein versus PTFE for above-knee femoropopliteal bypass: a review of the literature","volume":"27","author":"Klinkert","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Suppl","key":"10.1016\/j.jvs.2022.11.062_bib11","doi-asserted-by":"crossref","first-page":"126s","DOI":"10.1016\/j.jvs.2018.01.071","article-title":"A\u00a0systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia","volume":"69","author":"Almasri","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1067\/mva.2000.111279","article-title":"A\u00a0comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts","volume":"32","author":"Faries","year":"2000","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jvs.2017.09.017","article-title":"Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass","volume":"67","author":"Piffaretti","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib14","first-page":"CD000535","article-title":"Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery","volume":"4","author":"Brown","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2022.11.062_bib15","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2022.11.062_bib16","first-page":"CD000535","article-title":"Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery","volume":"2","author":"Bedenis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2022.11.062_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2022.11.062_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2022.11.062_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib19","first-page":"CD000536","article-title":"Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery","volume":"6","author":"Geraghty","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2022.11.062_bib20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jvs.2020.06.127","article-title":"Effects of dual antiplatelet therapy on graft patency after lower extremity bypass","volume":"73","author":"Belkin","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.avsg.2019.04.029","article-title":"Analysis of thirty-day readmission after infrainguinal bypass","volume":"61","author":"Bluemn","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib22","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jvs.2020.02.021","article-title":"Bleeding and thrombotic outcomes associated with postoperative use of direct oral anticoagulants after open peripheral artery bypass procedures","volume":"72","author":"Obi","year":"2020","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib23","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2022.11.062_bib24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.121.054835","article-title":"Effect of rivaroxaban and aspirin in patients with peripheral artery disease undergoing surgical revascularization: insights from the VOYAGER PAD trial","volume":"144","author":"Debus","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.11.062_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2018.01.011","article-title":"Rationale and design for the vascular outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)","volume":"199","author":"Capell","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2022.11.062_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/clc.23926","article-title":"Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a \u201cCASPAR like\u201d outcome from VOYAGER PAD","author":"Bonaca","year":"2022","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jvs.2022.11.062_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1067\/mva.2000.106496","article-title":"A\u00a0prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting","volume":"32","author":"Burger","year":"2000","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/0003319719826460","article-title":"Vein versus prosthetic graft for femoropopliteal bypass above the knee: a systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"Sharrock","year":"2019","journal-title":"Angiology"},{"key":"10.1016\/j.jvs.2022.11.062_bib29","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2022.11.062_bib30","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejvs.2018.02.015","article-title":"Editor's choice \u2013 a comparison of clinical outcomes between primary bypass and secondary bypass after failed plain balloon angioplasty in the bypass versus angioplasty for severe ischaemia of the limb (BASIL) trial","volume":"55","author":"Meecham","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jacc.2018.10.002","volume":"73","author":"Bailey","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jvs.2022.11.062_bib32","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Suppl","key":"10.1016\/j.jvs.2022.11.062_bib33","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib35","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization","volume":"142","author":"Hiatt","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.11.062_bib36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (the Dutch bypass oral anticoagulants or aspirin study): a randomised trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2022.11.062_bib37","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/CIRCULATIONAHA.104.518738","article-title":"Is duplex surveillance of value after leg vein bypass grafting? Principal results of the vein graft surveillance randomised trial (VGST)","volume":"112","author":"Davies","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2022.11.062_bib38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0741-5214(94)90289-5","article-title":"Duplex scan surveillance of infrainguinal prosthetic bypass grafts","volume":"20","author":"Lalak","year":"1994","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2022.11.062_bib39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1055\/s-0040-1713376","article-title":"Dual pathway inhibition for vascular protection in patients with atherosclerotic disease: rationale and review of the evidence","volume":"120","author":"Weitz","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2022.11.062_bib40","first-page":"2090","article-title":"Rivaroxaban in peripheral\u00a0artery disease after revascularization","volume":"383","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521422026015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521422026015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:39:21Z","timestamp":1760042361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521422026015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0741521422026015"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2022.11.062","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2022.11.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}